PTPRC and metabolic dysfunction-associated steatohepatitis: We observed a significant increase in leukocytes (CD45+ cells) in the experimental model of NASH (FF vs. normal; 37.9 ± 2.9% vs. 21.3 ± 1.08%, Fig. 3a, p < 0.0001).